Gilberto Lopes

12.6k citations

221 papers · 3.7k indexed · 1 hit paper · h-index 35

Impact in

Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in ⓘ

Oncology 131
- Colorectal Cancer Treatments and Studies 36
- Cancer Immunotherapy and Biomarkers 31
- Cancer Treatment and Pharmacology 21
- Lung Cancer Research Studies 19
Pulmonary and Respiratory Medicine 94
- Lung Cancer Treatments and Mutations 68

Co-authors: Benjamin Haaland (22 shared papers)Pedro Nazareth Aguiar (22 shared papers)Pui San Tan (10 shared papers)Alberto J. Montero (11 shared papers)Hakaru Tadokoro (8 shared papers)Ramon Andrade de Mello (7 shared papers)Geoffrey Y. Ku (7 shared papers)Stefan Glück (10 shared papers)
Journals: Journal of Clinical Oncology (38 papers)Journal of Thoracic Oncology (13 papers)Annals of Oncology (11 papers)Breast Cancer Research and Treatment (9 papers)JCO Global Oncology (7 papers)
Partner nations: United States Brazil Singapore

In The Last Decade

Gilberto Lopes

204 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study 2022 · 151 citations

Peers

Countries citing papers authored by Gilberto Lopes

Since Specialization

Citations

This map shows the geographic impact of Gilberto Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilberto Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilberto Lopes more than expected).

Fields of papers citing papers by Gilberto Lopes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilberto Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilberto Lopes. The network helps show where Gilberto Lopes may publish in the future.

Co-authors

The 25 scholars most cited alongside Gilberto Lopes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilberto Lopes Line = papers co-authored together Gilberto Lopes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small-Cell Lung Cancer: Updated Survival Data Immunotherapy ·Pedro Nazareth Aguiar, Ramon Andrade de Mello, Peter Hall, Hakaru Tadokoro, Gilberto Lopes	2017	157
2	Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study Journal of Clinical Oncology ·Gilberto de Castro, Iveta Kudaba, Yi‐Long Wu, Gilberto Lopes, Dariusz M. Kowalski, H.Z. Turna, Christian Caglevic, Li Zhang, Bogusława Karaszewska, К. К. Лактионов, Vichien Srimuninnimit, Igor Bondarenko, Kaoru Kubota, Rinee Mukherjee, Jianxin Lin, Fabricio Souza, Tony Mok, Byoung Chul Cho Hit paper breakdown →	2022	151
3	The Role of PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis Immunotherapy ·Pedro Nazareth Aguiar, Ilka Lopes Santoro, Hakaru Tadokoro, Gilberto Lopes, Bruno Andraus Filardi, Pedro F. Oliveira, Giannis Mountzios, Ramon Andrade de Mello	2016	120
4	How Uncommon are Isolated Lung Metastases in Colorectal Cancer? A Review from Database of 754 Patients Over 4 Years Journal of Gastrointestinal Surgery ·Ker‐Kan Tan, Gilberto Lopes, Richard Sim	2008	103
5	Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients WithEGFR-Mutated Advanced Non–Small Cell Lung Cancer JAMA Oncology ·Pedro Nazareth Aguiar, Benjamin Haaland, Wungki Park, Pui San Tan, Auro del Giglio, Gilberto Lopes	2018	97
6	A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer American Journal of Clinical Oncology ·Peter J. Hosein, Gilberto Lopes, Vitor H. Pastorini, C. Gomez, Jessica MacIntyre, Gloria Zayas, Isildinha M. Reis, Alberto J. Montero, Jaime R. Merchan, Caio M. Rocha Lima	2012	84
7	LBA4 Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in Keynote-042 Annals of Oncology ·Roy S. Herbst, Gilberto Lopes, Dariusz M. Kowalski, Kazuo Kasahara, Yuanqiang Wu, Gilberto de Castro, Byoung Chul Cho, H.Z. Turna, Răzvan Cristescu, Deepti Aurora-Garg, Jared Lunceford, Julie Kobie, Mark Ayers, M. Catherine Pietanza, Bilal Piperdi, Tony Mok	2019	79
8	Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort Cancer Immunology Immunotherapy ·Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H. Owen, Vaia Florou, Yukihiro Toi, Cynthia R. Cherry, Maida Hafiz, Andrea De Giglio, Mahvish Muzaffar, Sandip H. Patel, Shunichi Sugawara, Jarred Burkart, Wungki Park, Rita Chiari, Jun Sugisaka, Gregory A. Otterson, Gilberto Lopes, Paul R. Walker	2020	72
9	Changing global policy to deliver safe, equitable, and affordable care for women’s cancers The Lancet ·Ophira Ginsburg, Rajan Badwe, Peter Boyle, Gemma Derrick, Anna Dare, Tim Evans, Alexandru Eniu, Jorge Mario Gómez Jiménez, Tezer Kutluk, Gilberto Lopes, Sulma I. Mohammed, You‐Lin Qiao, Sabina Faiz Rashid, Diane Summers, Diana Sarfati, Marleen Temmerman, Edward L. Trimble, Aasim I. Padela, Ajay Aggarwal, Richard Sullivan	2016	71
10	Access to cancer medications in low- and middle-income countries Nature Reviews Clinical Oncology ·Gilberto Lopes, Jonas A. de Souza, Carlos H. Barrios	2013	70
11	Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer Breast Cancer Research and Treatment ·Christopher Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell, Connie Higgins, Erin Hurley, Judith Hurley, Isildinha M. Reis, Stephen P. Richman, Pearl H. Seo, Orlando Silva, Joyce M. Slingerland, K. Tukia, Catherine F. Welsh, Stefan Glück	2010	68
12	Meta-Analysis of First-Line Therapies in Advanced Non–Small-Cell Lung Cancer Harboring EGFR-Activating Mutations Journal of Thoracic Oncology ·Benjamin Haaland, Pui San Tan, Gilberto de Castro, Gilberto Lopes	2014	67
13	Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe? Current Oncology Reports ·Alberto J. Montero, Mauricio A. Escobar, Gilberto Lopes, Stefan Glück, Charles L. Vogel	2011	67
14	Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes Journal of Clinical Oncology ·Lawrence N. Shulman, Claire Wagner, Ronald D. Barr, Gilberto Lopes, Giuseppe Longo, Jane Robertson, Gilles Forte, Julie Torode, Nicola Magrini	2015	67
15	Lung cancer in Brazil Jornal Brasileiro de Pneumologia ·Luiz H. Araujo, Clarissa Baldotto, Gilberto de Castro, Artur Katz, Carlos Gil Ferreira, Clarissa Mathias, Eldsamira Mascarenhas, Gilberto Lopes, Heloísa de Andrade Carvalho, Jaques Tabacof, Jeovany Martínez-Mesa, Luciano de Souza Viana, M. Cruz, Mauro Zukin, Pedro De Marchi, Ricardo Mingarini Terra, Ronaldo A. Ribeiro, Vladmir Cláudio Cordeiro de Lima, Gustavo Werutsky, Carlos H. Barrios	2018	64
16	Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline Journal of Global Oncology ·Gilberto Lopes, Mariana C. Stern, Sarah Temin, Ala I. Sharara, Andrés Cervantes, Ainhoa Costas‐Chavarri, R. Engineer, Chisato Hamashima, Gwo Fuang Ho, Fidel David Huitzil, Mona Malekzadeh, Govind Nandakumar, Manish A. Shah, Catherine Teh, Sara E. Vázquez Manjarrez, Azmina Verjee, Rhonda K. Yantiss, Marcia Cruz Correa	2019	64
17	Barriers in access to oncology drugs — a global crisis Nature Reviews Clinical Oncology ·Carlos H. Barrios, Gilberto Lopes, Mastura Md Yusof, Fidel Rubagumya, Piotr Rutkowski, Manju Sengar	2022	60
18	Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012 The Lancet Oncology ·Geoffrey Y. Ku, Iain BeeHuat Tan, Thomas Yau, Narikazu Boku, Sudsawat Laohavinij, Ann‐Lii Cheng, Yoon‐Koo Kang, Gilberto Lopes	2012	60
19	Advanced-Stage Non–Small Cell Lung Cancer: Advances in Thoracic Oncology 2018 Journal of Thoracic Oncology ·Jordi Remón, Myung‐Ju Ahn, Nicolas Girard, Melissa L. Johnson, Dong‐Wan Kim, Gilberto Lopes, Rathi N. Pillai, Benjamin Solomon, Guillermo Villacampa, Qing Zhou	2019	60
20	Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials Lung Cancer ·Geoffrey Y. Ku, Benjamin Haaland, Gilberto Lopes	2011	60

About Gilberto Lopes

Gilberto Lopes is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 221 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (68 papers), Economic and Financial Impacts of Cancer (37 papers), Colorectal Cancer Treatments and Studies (36 papers), Cancer Immunotherapy and Biomarkers (31 papers), Cancer Genomics and Diagnostics (27 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers), Cancer Treatment and Pharmacology (21 papers) and Lung Cancer Research Studies (19 papers). The work is most often cited by research in Oncology (2.2k citations), Pulmonary and Respiratory Medicine (1.5k citations), Cancer Research (607 citations), Economics and Econometrics (482 citations) and Immunology (323 citations). Gilberto Lopes has collaborated with scholars based in United States, Brazil and Singapore. Frequent co-authors include Benjamin Haaland, Pedro Nazareth Aguiar, Pui San Tan, Alberto J. Montero, Hakaru Tadokoro, Ramon Andrade de Mello, Geoffrey Y. Ku, Stefan Glück, Carlos H. Barrios and Gilberto de Castro. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Breast Cancer Research and Treatment and JCO Global Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact